Sunzen Biotech Berhad Statistics

Total Valuation

Sunzen Biotech Berhad has a market cap or net worth of MYR 245.80 million. The enterprise value is 236.31 million.

Market Cap	245.80M
Enterprise Value	236.31M

Important Dates

The next estimated earnings date is Sunday, November 24, 2024.

Earnings Date	Nov 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Sunzen Biotech Berhad has 780.32 million shares outstanding. The number of shares has increased by 0.56% in one year.

Current Share Class	n/a
Shares Outstanding	780.32M
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	-8.59%
Owned by Insiders (%)	55.26%
Owned by Institutions (%)	n/a
Float	315.33M

Valuation Ratios

The trailing PE ratio is 42.96.

PE Ratio	42.96
Forward PE	n/a
PS Ratio	2.34
PB Ratio	1.61
P/TBV Ratio	n/a
P/FCF Ratio	26.71
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.93, with an EV/FCF ratio of 25.68.

EV / Earnings	39.21
EV / Sales	2.48
EV / EBITDA	17.93
EV / EBIT	21.85
EV / FCF	25.68

Financial Position

The company has a current ratio of 7.11, with a Debt / Equity ratio of 0.05.

Current Ratio	7.11
Quick Ratio	5.56
Debt / Equity	0.05
Debt / EBITDA	0.57
Debt / FCF	0.83
Interest Coverage	38.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+23.53%
50-Day Moving Average	0.33
200-Day Moving Average	0.33
Relative Strength Index (RSI)	40.68
Average Volume (20 Days)	945,740

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sunzen Biotech Berhad had revenue of MYR 95.12 million and earned 6.03 million in profits. Earnings per share was 0.01.

Revenue	95.12M
Gross Profit	25.55M
Operating Income	11.09M
Pretax Income	10.57M
Net Income	6.03M
EBITDA	13.07M
EBIT	11.09M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 27.60 million in cash and 7.66 million in debt, giving a net cash position of 19.94 million or 0.03 per share.

Cash & Cash Equivalents	27.60M
Total Debt	7.66M
Net Cash	19.94M
Net Cash Per Share	0.03
Equity (Book Value)	149.84M
Book Value Per Share	0.20
Working Capital	49.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.82 million and capital expenditures -620,285, giving a free cash flow of 9.20 million.

Operating Cash Flow	9.82M
Capital Expenditures	-620,285
Free Cash Flow	9.20M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 26.86%, with operating and profit margins of 11.66% and 6.34%.

Gross Margin	26.86%
Operating Margin	11.66%
Pretax Margin	11.11%
Profit Margin	6.34%
EBITDA Margin	13.74%
EBIT Margin	11.66%
FCF Margin	9.67%

Dividends & Yields

Sunzen Biotech Berhad does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.56%
Shareholder Yield	-0.56%
Earnings Yield	2.33%
FCF Yield	3.74%

Stock Splits

The last stock split was on April 29, 2015. It was a forward split with a ratio of 1.5.

Last Split Date	Apr 29, 2015
Split Type	Forward
Split Ratio	1.5

Scores

Sunzen Biotech Berhad has an Altman Z-Score of 6.95.

Altman Z-Score	6.95
Piotroski F-Score	n/a